Group 1 - The core point of the news is that Kingmed Diagnostics experienced a decline of 5.34% in its stock price, reaching 34.05 CNY per share, with a trading volume of 279 million CNY and a turnover rate of 1.73%, resulting in a total market capitalization of 15.774 billion CNY [1] - Kingmed Diagnostics, established on May 26, 2006, and listed on September 8, 2017, is located in Guangzhou, Guangdong Province, and provides a wide range of diagnostic services to over 23,000 medical institutions across China [1] - The company's main business revenue composition includes medical diagnostic services at 91.20%, sales of diagnostics at 6.45%, other services at 1.47%, cold chain logistics at 0.62%, and health check-up services at 0.27% [1] Group 2 - From the perspective of major fund holdings, one fund under Great Wall Fund has a significant position in Kingmed Diagnostics, with Great Wall Consumer Value Mixed A (200006) reducing its holdings by 1.3 million shares in the third quarter, now holding 1.3005 million shares, which accounts for 4.58% of the fund's net value [2] - The fund has reported a floating loss of approximately 2.497 million CNY as of the latest update [2] - Great Wall Consumer Value Mixed A (200006) was established on April 6, 2006, with a current scale of 516 million CNY, and has achieved a year-to-date return of 21.73%, ranking 56 out of 8,847 in its category [2]

Group 1 - The core point of the news is that Kingmed Diagnostics has experienced a significant decline in stock price, dropping 5.02% on September 23, with a total market value of 13.32 billion yuan and a cumulative decline of 7.15% over six consecutive days [1] - Kingmed Diagnostics, established on May 26, 2006, and listed on September 8, 2017, provides a wide range of medical testing services to over 23,000 medical institutions across China, including nearly 80 types of testing technologies and approximately 3,200 testing projects [1] - The company's main business revenue composition includes: medical diagnostic services at 91.20%, sales of diagnostics at 6.45%, other services at 1.47%, cold chain logistics at 0.62%, and health check-up services at 0.27% [1] Group 2 - From the perspective of fund holdings, one fund under Chuangjin Hexin has a significant position in Kingmed Diagnostics, with 311,000 shares held, accounting for 4.5% of the fund's net value, ranking as the eighth largest holding [2] - The fund has incurred a floating loss of approximately 472,700 yuan today and a total floating loss of 724,600 yuan during the six-day decline [2] - The Chuangjin Hexin Medical Consumption Stock A fund, established on December 3, 2020, has a current scale of 173 million yuan, with a year-to-date return of 3.63% and a one-year return of 17.93% [2]